ライフサイエンスコーパス: progesterone

1 ure bound to the other substrate (17alpha-OH-progesterone).

2 f the ovarian steroid hormones, estrogen and progesterone.

3 and the second and third months of estradiol/progesterone.

4 tely gain or lose binding in the presence of progesterone.

5 drocortisone inhibited CatSper activation by progesterone.

6 uprolide plus estradiol; and leuprolide plus progesterone.

7 PG-2) exhibited exceptional selectivity for progesterone.

8 ndocrine gland that synthesizes and secretes progesterone.

9 steroid synthesis pathway and reduced serum progesterone.

10 o develop this TF into an optical sensor for progesterone.

11 ol via a series of enzymatic reactions, into progesterone.

12 regnancy rates through the quantification of progesterone.

13 ver was dexamethasone (<2.54-43.56 ng/g) and progesterone (2.23-9.78 ng/g), and in the reproductive o

14 women in both groups were prescribed vaginal progesterone, 200 mg/d, until 36 weeks 6 days of gestati

15 d Kingdom, were randomly assigned to receive progesterone (2079 women) or placebo (2074 women).

16 regnanolone (10 mg/kg, IP) and attenuated by progesterone (30 mg/kg, IP) in SD-subjected, but not con

17 e effects can be prevented by treatment with progesterone, a clinically approved strategy.

18 al trophoblasts serve as the major source of progesterone, a steroid hormone known to affect the repl

19 lation that is designed for improved vaginal progesterone absorption and vaginal biocompatibility cou

20 sis involved a condensation reaction between progesterone acetate and thiosemicarbazone hydrochloride

21 sperm from the sperm reservoir is induced by progesterone action through CatSper channels.

22 ur data suggest that 19-norprogesterone- and progesterone-activated MR may have unappreciated functio

23 Although progesterone activates MRs in ray-finned fish, progester

24 Even at postmenopausal concentrations, progesterone activates PR-A, inducing invasiveness by co

25 Instead, the data indicate that placental progesterone acts as substrate for synthesis of backdoor

26 Maternal progesterone administration altered fetal pituitary and

27 In addition, progesterone administration attenuated EGFR/PI3K/Akt/mTO

28 Little is known about effects of progesterone administration in early pregnancy on fetal

29 Maternal progesterone administration increased male, but not fema

30 Compared to controls, high-dose progesterone administration produced a significant reduc

31 sterone supplementation would increase fetal progesterone, affect progesterone target tissues in the

32 ne transcription was robustly induced by the progesterone agonist R5020, leading to a dramatically hi

33 ive both estradiol and progesterone, but not progesterone alone.

34 High-dose progesterone also induced senescence in GBM as evidenced

35 ich endogenous fluctuations in estradiol and progesterone alter functional cerebellar networks at res

36 ments in appetite and/or body weight include progesterone analogs and corticosteroids.

37 logic interventions that may be used include progesterone analogs and short-term (weeks) corticostero

38 esult is a hyperactive pathway, initiated by progesterone and amplified by DNA damage-induced NF-kapp

39 evealed robust negative associations between progesterone and cerebellar coherence.

40 Triple-negative breast cancers (TNBCs) lack progesterone and estrogen receptors and do not have ampl

41 ut (AG129) female mice were pre-treated with progesterone and inoculated intravaginally with artifici

42 Progesterone and its receptor, PR, are essential for ute

43 a structure of WT human P450 21A2 with bound progesterone and now present a structure bound to the ot

44 nesis, catalyzing the two-step oxidations of progesterone and pregnenolone to androstenedione and deh

45 Surprisingly, we found that alterations in progesterone and progesterone receptor (Pgr) signalling

46 The MR binds progesterone and spironolactone as antagonists in human

47 vated basal oxytocin, lower ACTH, estradiol, progesterone and testosterone compared with non-OC users

48 renocorticotropic hormone (ACTH), estradiol, progesterone and testosterone.

49 Synergy between the inhibitory effect of progesterone and the efflux pump inhibitors verapamil an

50 Collectively, these studies suggest progesterone and the PR promote BoHV-1 spread to reprodu

51 These studies suggest that the ability of progesterone and the PR to stimulate productive infectio

52 Since progesterone and the progesterone receptor (PR) can acti

53 We now demonstrate that progesterone and the progesterone receptor (PR) stimulat

54 he 17alpha-hydroxylation of pregnenolone and progesterone and the subsequent 17alpha,20-lyase reactio

55 icosterone, corticosterone, 11-deoxcortisol, progesterone, and 19-norprogesterone are potential physi

56 as assessed by immunostaining for estrogen, progesterone, and Her2 receptors (ER/PR/Her2).

57 reast cancer (testing negative for estrogen, progesterone, and Her2 receptors) has elevated GLS prote

58 We found that the 17alpha-OH-progesterone- and progesterone-bound complex structures

59 also includes receptors for glucocorticoids, progesterone, androgens, and estrogens.

60 Bioaffinity studies towards anti-progesterone antibodies involved a competitive ELISA for

61 h optimum binding and surface conditions for progesterone antigen-antibody interaction with the assis

62 -blind, placebo-controlled trial to evaluate progesterone, as compared with placebo, in women with va

63 ing of 17alpha-OH pregnenolone or 17alpha-OH progesterone, as judged by the apparent K(d) and binding

64 that DRP1 is required for optimal LH-induced progesterone biosynthesis.

65 d the prolonged cycle length and rescued the progesterone blockade LH surge, while RU486 into the ARC

66 found that the 17alpha-OH-progesterone- and progesterone-bound complex structures are highly similar

67 G-3 cells, C. burnetii showed sensitivity to progesterone but not the immediate precursor pregnenolon

68 effect when mice receive both estradiol and progesterone, but not progesterone alone.

69 The sensitivity of C. burnetii to progesterone, but not structurally related molecules, is

70 icles, consistent with dramatic reduction of progesterone by 24 h after hCG administration.

71 rticularly when cells are hypersensitized to progesterone by PR-A overexpression.

72 In addition, progesterone bypasses the transcriptional elongation blo

73 Given that progesterone can regulate both timing of trophoblast elo

74 Finally, we showed that treatment with progesterone can serve as a strategy to prevent preterm

75 rmed by reduced expression of BAT markers in progesterone challenged oophorectomised mice.

76 during the first month of combined estradiol/progesterone compared with the last month of leuprolide

77 e were no adverse events related to DMPA and progesterone concentrations were <1 ng/mL for all women

78 were no adverse events related to DMPA, and progesterone concentrations were <1 ng/mL for all women

79 Endogenous progesterone concentrations were lower in male than fema

80 ration increased male, but not female, fetal progesterone concentrations, also increasing circulating

81 early pregnancy on maternal and fetal plasma progesterone concentrations, transcript abundance in the

82 Estrogens and progesterone control breast development and carcinogenes

83 Further, improved vaginal progesterone delivery by the nanosuspension led to incre

84 ependent on pregnancy hormones (estrogen and progesterone), delta-opioid receptors, and T cells of th

85 Uterine Galpha(q/11) signaling, in a progesterone-dependent manner, critically regulates the

86 atments of estrogen replacement therapy, the progesterone derivative allopregnanolone, and testostero

87 emical interrogation of a novel redox active progesterone derivative progesterone thiosemicarbazone (

88 ical) which confirmed recognition of the new progesterone derivative.

89 se was specific; pregnenolone and 17alpha-OH-progesterone did not affect sperm release.

90 Treatment with progesterone did not mitigate poorly differentiated aden

91 ogesterone activates MRs in ray-finned fish, progesterone does not activate MRs in humans, amphibians

92 Importantly, the unique plasma progesterone double peak observed in humans, reflecting

93 Sex hormones, in particular progesterone, drive the development of thymic T(reg) cel

94 The anti-progesterone drug mifepristone and the prostaglandin mis

95 tudy the mechanism of the protective role of progesterone during pregnancy, we investigated the effec

96 hat prednisone, fluticasone, budesonide, and progesterone each increased cAMP levels within 3 minutes

97 Oestradiol, oestrone, oestriol and progesterone each related to autism in univariate analys

98 In the ruminant, one action of progesterone early in pregnancy is to alter embryonic de

99 d DKK1 expression, DKK1 may be a mediator of progesterone effects on embryonic development.

100 2 exhibited progesterone, estrogen, androgen, and pregnane X recepto

101 Furthermore, progesterone exhibited an inhibitory effect on nuclear f

102 For the 882 patients enrolled in Progesterone for the Treatment of Traumatic Brain Injury

103 ardize care across 42 sites participating in Progesterone for the Treatment of Traumatic Brain Injury

104 The Progesterone for the Treatment of Traumatic Brain Injury

105 We demonstrate that a progesterone formulation that is designed for improved v

106 oductive stage or by fecal estrogen (fE) and progesterone (fP) concentrations.

107 pharmacodynamics to the clinical comparator progesterone gel in pregnant mice and demonstrate increa

108 Further, vaginal products like progesterone gel often contain excipients that cause loc

109 ted that boar spermatozoa are attracted by a progesterone gradient.

110 estation was 75% (1513 of 2025 women) in the progesterone group and 72% (1459 of 2013 women) in the p

111 High concentrations of progesterone (>19 ng/g, wet weight), recognised as an in

112 ratios showed that oestradiol, oestrone and progesterone had the largest effects on autism likelihoo

113 igation into its suitability as conjugate in progesterone hormone immunosensing.

114 The sensor detects progesterone in artificial urine with sufficient sensiti

115 ral ESC/E(Z) complex genes were increased by progesterone in controls only, and decreased by estradio

116 be fetal sex specific effects of the use of progesterone in early pregnancy, and highlights that pro

117 treatment augmented the calcium response to progesterone in human spermatozoa.

118 acy in preventing preterm birth with vaginal progesterone in this model.

119 one in XY-KO mice and marked accumulation of progesterone in XX-KO mice.

120 t day + 7 of transplantation, while salivary progesterone increased at day + 7 and + 14.

121 Progesterone increased sperm intracellular Ca(2+), which

122 rence human agonist ligands promegestone and progesterone induced luciferase activity in both cell li

123 NNC 055-0396 also blocked the progesterone-induced sperm release from oviduct cells or

124 Rather, we find that the pregnancy hormone progesterone induces PDK4 (pyruvate dehydrogenase kinase

125 18MG tumor cells, we observed that high-dose progesterone inhibited expression of Glut1, which facili

126 This study examined the hypothesis that progesterone inhibits LH surge and pulsatile secretion v

127 In conclusion, progesterone inhibits the modulators of glycolytic metab

128 signaling sustain greater FRT infection when progesterone is administered.

129 Serum progesterone level was significantly (p = 0.026) elevate

130 evels were negatively correlated with plasma progesterone levels but positively correlated with plasm

131 Natural plasma progesterone levels did not correlate with any of these

132 ngs demonstrate that the change in estradiol/progesterone levels from low to high, and not the steady

133 gnenolone sulfate exerted similar effects as progesterone, likely binding to the same site.

134 g the transition to terrestrial vertebrates, progesterone lost the ability to activate the MR.

135 These results reveal a novel mechanism that progesterone may play an important role in decreasing mu

136 tra-individual fluctuations in estradiol and progesterone may provide unique insight into the effects

137 t with a role for efflux pumps in preventing progesterone-mediated inhibition of C. burnetii activity

138 These data demonstrate that progesterone mediates a phenotypic change in BAT, which

139 d testosterone), progestins and metabolites (progesterone, medroxyprogesterone acetate, megestrol ace

140 s through Adrenergic receptor b2 (Adrb2) and Progesterone membrane receptor component 1 (Pgrmc1), whi

141 Additionally, urinary estradiol and progesterone metabolites were measured daily surrounding

142 three key hormones- oxytocin, estrogen, and progesterone-modulate and integrate excitability through

143 ion scores in the second and third estradiol/progesterone months did not significantly differ.

144 , human chorionic gonadotropin [n = 68 181], progesterone [n = 41 628], and estrogen [n = 16 948]) an

145 and characterization of a mucoinert vaginal progesterone nanosuspension formulation for improved dru

146 The effect of progesterone on sperm release was specific; pregnenolone

147 n, the differential effects of estradiol and progesterone on these uterine leiomyoma subtypes emphasi

148 the effect of physiologic concentrations of progesterone on tight junction protein occludin expressi

149 novel observation that treatment with either progesterone or a synthetic analog found in hormonal con

150 al suppositories containing either 400 mg of progesterone or matching placebo twice daily, from the t

151 t, athymic nude mice received treatment with progesterone or vehicle for 40 days.

152 Progesterone (P4) has been used for several decades in e

153 We and others have demonstrated that progesterone (P4) increases CK5+ breast cancer cells.

154 Clasically, progesterone (P4) is known to inhibit the expression of

155 on d 4 of pregnancy, despite adequate serum progesterone (P4) levels and normal P4 receptor (PR) exp

156 The steroid hormone progesterone (P4) mediates many physiological processes

157 tress, and the pregnancy maintenance hormone progesterone (P4) reversed this process.

158 Progesterone (P4) signaling is crucial for the deciduali

159 We studied the impact of estradiol (E2) and progesterone (P4), which impregnate the fetus during pre

160 Infusion of E2 and progesterone (P4; hormone control) over 7 d resulted in

161 Progesterone plays a protective role in preventing infla

162 te a complex regulatory network that affects progesterone/PR-mediated RANKL gene expression, with an

163 B (RANKL) was recently identified as a novel progesterone/PR-responsive gene that plays an important

164 sterone to influence pathogen replication in progesterone-producing tissues.

165 bitor of DRP1 increased basal and LH-induced progesterone production.

166 ng delivery of substrate to mitochondria for progesterone production.

167 ediator of the acute actions of LH on luteal progesterone production.

168 iated knock down of HSL abrogated LH-induced progesterone production.

169 contraceptives contain a dose of a synthetic progesterone (progestin) or a combination of a progestin

170 iferative effects, depending on the estrogen/progesterone ratio.

171 le-negative breast cancer (estrogen receptor/progesterone receptor < 10%), and five had hormone recep

172 natural and synthetic ligands of the nuclear progesterone receptor (nPR) has been pointed out, howeve

173 ble gene 6 (Mig-6) is a critical mediator of progesterone receptor (PGR) action in the uterus.

174 Progesterone receptor (PGR) co-ordinately regulates ovul

175 ifferences in the relative abundances of the progesterone receptor (PGR) isoforms PGRA and PGRB are o

176 For example, we find that Progesterone Receptor (PGR) phosphorylation is associate

177 e found that alterations in progesterone and progesterone receptor (Pgr) signalling strongly suppress

178 n of the steroid has a significant impact on progesterone receptor (PR) and androgen receptor (AR) ac

179 major receptors i.e. estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth fa

180 e have identified an interaction between the progesterone receptor (PR) and STAT1 in breast cancer ce

181 Estrogen receptor (ER) and progesterone receptor (PR) are important prognostic and

182 Since progesterone and the progesterone receptor (PR) can activate many GREs, we hy

183 T/CT imaging of tumor glucose metabolism and progesterone receptor (PR) expression, respectively.

184 Ulipristal acetate (UPA) a selective progesterone receptor (PR) modulator (SPRM) reduce the s

185 ha) reactivity, but have decreased levels of progesterone receptor (PR) protein.

186 We now demonstrate that progesterone and the progesterone receptor (PR) stimulate productive infectio

187 ER and progesterone receptor (PR) were significantly lower in m

188 Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth f

189 t cancer risk and by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth f

190 r (ER)-positive breast cancers coexpress the progesterone receptor (PR), which can directly and globa

191 ve cells), and MCF-7 (estrogen receptor (ER)/progesterone receptor (PR)-positive cell line) with negl

192 resulting from its ability to antagonize the progesterone receptor (PR).

193 one receptor antagonists (ER/ICI 182,780, or progesterone receptor (PR)/ RU486) for 48 h.

194 Invasive tumors overexpress the short progesterone receptor A (PR-A) isoform.

195 MetaCore Enrichment analysis identified progesterone receptor action and transforming growth fac

196 ng tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor

197 e PTBs induced by bacterial endotoxin LPS or progesterone receptor antagonist mifepristone more often

198 Moreover, progesterone receptor antagonist RU-486 partially revers

199 However, microinjection of the progesterone receptor antagonist, RU486, into the AVPV r

200 3) A tendency for decreased expression of progesterone receptor co-activators (NCOA1, -2 and -3, a

201 ke kinase 5 (ALK5) in the mouse uterus using progesterone receptor cre ("Alk5 cKO") that develops end

202 e EZH2, Ezh2 was conditionally deleted using progesterone receptor Cre recombinase, which is expresse

203 t cancer cells characterized by estrogen and progesterone receptor expression (ER+/PR+), to more basa

204 ubtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplific

205 mical analysis was positive for estrogen and progesterone receptor expression and negative for human

206 ogen receptor expression (50%), negative for progesterone receptor expression, and had a Ki-67 score

207 cT2 to 4b, any N, M0; estrogen receptor and progesterone receptor greater than 50%; human epidermal

208 ore (228; median reduction, 15.0; P = .005), progesterone receptor H-score (15; median reduction, 85.

209 uman amnion mesenchymal cells (AMCs) through progesterone receptor membrane component 2 (PGRMC2) and

210 Here we show that progesterone receptor membrane component 2 (PGRMC2) is r

211 igated continuous treatment with a selective progesterone receptor modulator, ulipristal acetate (UPA

212 ury was not associated with child cognition, progesterone receptor rs1042838 minor alleles revealed a

213 ncomplete data on oestrogen receptor status, progesterone receptor status, or HER2 status were exclud

214 history of CNS metastases, and oestrogen and progesterone receptor status.

215 The expression of progesterone receptor target genes including the Indian

216 An inhibitor of the non-genomic progesterone receptor that activates CatSper similarly b

217 s transgenic mice in which the expression of progesterone receptor was genetically ablated.

218 his study for the minor allele of rs1042838 (progesterone receptor) (beta = -11.8, 95% confidence int

219 of hormone receptors (oestrogen receptor and progesterone receptor) and/or BRCA mutations.

220 ers that are negative for estrogen receptor, progesterone receptor, and ERBB2 (triple-negative breast

221 luding those lacking estrogen receptor (ER), progesterone receptor, and HER2 (known as triple-negativ

222 ich lacks estrogen receptor alpha (ERalpha), progesterone receptor, and human epidermal growth factor

223 ncer subtype lacking estrogen receptor (ER), progesterone receptor, and human epidermal growth factor

224 s; tumor size; grade; and estrogen receptor, progesterone receptor, and Ki-67 labeling index expressi

225 ferences were detected in estrogen receptor, progesterone receptor, beta-catenin, or vimentin express

226 verexpression of estrogen receptor alpha and progesterone receptor, loss of collagen, increase in pro

227 id not vary based on age, estrogen receptor, progesterone receptor, or HER2 status.

228 well as gain of PTK6 and the membrane-bound progesterone receptor, PAQR8.

229 Confirming the role of the progesterone receptor, the preventive effect of MPA was

230 ble-conditional knockout was generated using progesterone receptor-cre (Smad2/3 cKO) mice.

231 al knockout (cKO) of Fst in the uterus using progesterone receptor-cre to study the roles of uterine

232 was further tested in oestrogen receptor and progesterone receptor-labelled images.

233 specified subgroup analyses in patients with progesterone receptor-negative disease; patients with a

234 ive ductal carcinomas that were estrogen and progesterone receptor-positive (ER/PR+) and HER2/neu-neg

235 oid reexcision in estrogen receptor-positive progesterone receptor-positive cancer and 63% for estrog

236 ts suggest that MPA is efficient in treating progesterone receptor-positive CIN lesions.

237 ion of the estrogen responsive genes pS2 and progesterone receptor.

238 ancer and 63% for estrogen receptor-negative progesterone- receptor-negative cancer.

239 We find that progesterone-receptor (PR)-expressing neurons in the ven

240 Obtained results confirmed how Progesterone-Receptor assay represent a useful tool to s

241 ration in calves, based on quantification of progesterone-Receptor mRNA in bulbo-urethral gland sampl

242 (TNBC) that lack expression of estrogen and progesterone receptors (ER/PR), or amplification or over

243 protein-coupled receptors known as membrane progesterone receptors (mPRs).

244 Breast cancer lacking estrogen receptors, progesterone receptors and HER2 receptors are difficult

245 absence of molecular markers for estrogen or progesterone receptors and human epidermal growth factor

246 Estrogen and progesterone receptors are the established biomarkers th

247 C) nuclei, while the region-specific role of progesterone receptors in these nuclei remains unknown.

248 Devoid of the estrogen and progesterone receptors, along with the receptor tyrosine

249 e with mutations in the nuclear estrogen and progesterone receptors, suggesting a role in treatment r

250 iptional programs controlled by estrogen and progesterone receptors, without fully abrogating them.

251 variant, strongly positive for estrogen and progesterone receptors.

252 breast cancers express the oestrogen and/or progesterone receptors.

253 xpressed hormone receptors (oestrogen and/or progesterone receptors; HR(+)) but did not have high lev

254 nd transmission electron microscopy supports progesterone recognition lead to the generation of bulk

255 any GREs, we hypothesized that the PR and/or progesterone regulates productive infection and viral tr

256 Progesterone regulates the endometrium to support pregna

257 onfirmed that PGR proteins were recruited on progesterone response element of Gpr64 gene in the uteri

258 These DMRs are enriched at progesterone-responsive gene loci that are essential for

259 ered 0, 4, 8, 24 and 48 h after removal of a progesterone-secreting pellet).

260 We use this approach to identify a progesterone-sensing bacterial aTF and to develop this T

261 not the longer PR-B isoform, with increased progesterone sensitivity when PR-A was overexpressed.

262 The absence of a strong accompanying progesterone signal in these animals raises the possibil

263 tated in primary cancers, implicate membrane progesterone signaling and nuclear PKA in metastatic rec

264 New studies demonstrated that progesterone stimulated productive infection.

265 is not preceded by a decrease in circulating progesterone, suggesting that pregnancy loss is a local

266 Vaginal progesterone supplementation has been demonstrated to re

267 rone in early pregnancy, and highlights that progesterone supplementation should be used only when th

268 e hypothesised that maternal early pregnancy progesterone supplementation would increase fetal proges

269 ein kinase A (PKA) acutely stimulates luteal progesterone synthesis via a complex process, converting

270 tween PKA, HSL, and lipid droplets in luteal progesterone synthesis.

271 ment and maintenance of pregnancy depends on progesterone synthesized by luteal tissue in the ovary.

272 on would increase fetal progesterone, affect progesterone target tissues in the developing fetal repr

273 rong evidence that it derives from placental progesterone that is metabolized to androsterone in nont

274 mong women with bleeding in early pregnancy, progesterone therapy administered during the first trime

275 Several small trials have suggested that progesterone therapy may improve pregnancy outcomes in w

276 a novel redox active progesterone derivative progesterone thiosemicarbazone (PATC) is presented here

277 the major steroid 21-hydroxylase, converting progesterone to 11-deoxycorticosterone and 17alpha-hydro

278 analyzed the ability of corticosteroids and progesterone to activate the full-length MR from the ele

279 therefore, we tested directly the ability of progesterone to induce sperm release from oviduct cell a

280 molecules, is consistent with the ability of progesterone to influence pathogen replication in proges

281 Binding of the steroid progesterone to P450 21A2 was also best described by a c

282 and 17alpha-hydroxyprogesterone (17alpha-OH-progesterone) to 11-deoxycortisol.

283 o the ARC shortened LH pulse interval in the progesterone treated rats.

284 We investigated the effects of progesterone treatment during early pregnancy on materna

285 Progesterone treatment increased intestinal trans-epithe

286 onist DKK1, whose expression is increased by progesterone treatment, can act on the bovine embryo dur

287 We examined the effect of progesterone treatments on glycolytic metabolism and sen

288 that 15 microRNAs (miRNAs) are regulated by progesterone via PR-A, but not the longer PR-B isoform,

289 Using host cell-free culture, progesterone was determined to have a direct inhibitory

290 A chemotaxis experiment with 1 muM progesterone was performed that significantly demonstrat

291 only small proportions of the androgens and progesterone were conjugated.

292 Estrogens, androgens, and progesterone were detected in the examined milk samples

293 Plasma MPA concentrations and progesterone were measured pre-dose (MPA only), 2, 4, 6,

294 Plasma MPA concentrations and progesterone were measured predose (MPA only) and 2, 4,

295 ynthesizes and secretes the steroid hormone, progesterone, which is vital for establishment and maint

296 ized oviduct glycan and then challenged with progesterone, which stimulated the release of 48% of spe

297 l in these animals raises the possibility of progesterone withdrawal prior to parturition.

298 We adapted a mouse model of progesterone withdrawal that was previously believed to

299 creased during menstrual phase and 24 h post-progesterone-withdrawal respectively.

300 Compounds known to induce MT release like progesterone, ZnSO(4), quercetin, dexamethasone and apom